Johnson & Johnson was honored as one of Fast Company’s top ten most innovative biotech companies. Johnson & Johnson was recognized for its incubation of medical startups. Learn more about the ranking on Fast Company’s website. Check out JLABS to learn more about how we support startups.
Once considered a straightforward procedure to restore cloudy vision, cataract surgery has evolved into one of the most technologically advanced—and personalized—operations in modern medicine. Learn how Johnson & Johnson’s 25-year history of innovation is helping eye surgeons meet the moment.
The company’s ability to evolve as it tackles the world’s toughest health challenges has helped Johnson & Johnson earn its spot as the top-ranked healthcare company on the list.
Jordan Schecter, M.D., leader of Johnson & Johnson’s end-to-end development strategy for multiple myeloma, shares insight on the evolving treatment landscape of this rare blood cancer.
